Search results
Results from the WOW.Com Content Network
Asparaginase is an enzyme that is used as a medication and in food manufacturing. [6] [7] As a medication, L-asparaginase is used to treat acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL). [6] It is given by injection into a vein, or muscle. [6] A pegylated version is also available. [8] In food manufacturing it is used to ...
However, the opposite effect is visible in cases of asparaginase resistant cancers. [3] In these resistant cancers, the effect of blood asparagine depletion through L-asparaginase instead leads to significant asparagine synthetase overexpression to compensate, effectively nullifying the effect of the chemotherapy drug. [3]
There can be many years between promising laboratory work and the availability of an effective anti-cancer drug: Monroe Eliot Wall discovered anti-cancer properties in Camptotheca in 1958, but it was not until 1996 – after further research and rounds of clinical trials – that topotecan, a synthetic derivative of a chemical in the plant, was ...
The European Journal of Cancer Care is a bimonthly peer-reviewed medical journal covering research on cancer care. The editor-in-chief is David Weller (University of Edinburgh). The journal was established in 1992 and is published by Wiley-Blackwell.
Cancer Research UK say that milk thistle is promoted on the internet for its claimed ability to slow certain kinds of cancer, but that there is no good evidence in support of these claims. [88] Mistletoe – Anthroposophical medicine holds that harvesting it when the planets are aligned will yield a cancer treatment.
Cancer treatments are a wide range of treatments available for the many different types of cancer, with each cancer type needing its own specific treatment. [1] Treatments can include surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy including small-molecule drugs or monoclonal antibodies, [2] and PARP inhibitors such as olaparib. [3]
Vincristine, also known as leurocristine and marketed under the brand name Oncovin among others, is a chemotherapy medication used to treat a number of types of cancer. [5] This includes acute lymphocytic leukemia, acute myeloid leukemia, Hodgkin's disease, neuroblastoma, and small cell lung cancer among others. [5] It is given intravenously. [5]
Some α emitting isotopes such as 225 Ac and 213 Bi are only available in limited quantities from 229 Th decay, although cyclotron production is feasible. [9] [10] [11] Among alpha-emitting radiometals according to availability, chelation chemistry, and half-life, 212 Pb is also a promising candidate for targeted alpha-therapy.